1-3 of 3
Konstantin Schuschel
Close
Sort by
Journal Articles

TRIP13 Is a Fetal-Enriched Therapeutic Target in NUP98-JARID1A + Pediatric Non-Down Syndrome AMKL

Luca Nunzio Cifarelli, Hasan Issa, Konstantin Schuschel, Katja Menge, Lucie Gack, Christian Ihling, Andrea Sinz, Jan-Henning Klusmann, Dirk Heckl
Journal: Blood
Blood (2023) 142 (Supplement 1): 711.
https://doi.org/10.1182/blood-2023-182843
Published: 2023
Journal Articles

RUNX1 isoform disequilibrium promotes the development of trisomy 21–associated myeloid leukemia

Sofia Gialesaki, Daniela Bräuer-Hartmann, Hasan Issa, Raj Bhayadia, Oriol Alejo-Valle, Lonneke Verboon, Anna-Lena Schmell, Stephanie Laszig, Enikő Regényi, Konstantin Schuschel, Maurice Labuhn, Michelle Ng, Robert Winkler, Christian Ihling, Andrea Sinz, Markus Glaß, Stefan Hüttelmaier, Sören Matzk, Lena Schmid, Farina Josepha Strüwe, Sofie-Katrin Kadel, Dirk Reinhardt, Marie-Laure Yaspo, Dirk Heckl, Jan-Henning Klusmann
Journal: Blood
Blood (2023) 141 (10): 1105–1118.
https://doi.org/10.1182/blood.2022017619
Published: 2023
Includes: Supplemental data
Journal Articles

The megakaryocytic transcription factor ARID3A suppresses leukemia pathogenesis

Oriol Alejo-Valle, Karoline Weigert, Raj Bhayadia, Michelle Ng, Hasan Issa, Christoph Beyer, Stephan Emmrich, Konstantin Schuschel, Christian Ihling, Andrea Sinz, Martin Zimmermann, Claudia Wickenhauser, Marius Flasinski, Eniko Regenyi, Maurice Labuhn, Dirk Reinhardt, Marie-Laure Yaspo, Dirk Heckl, Jan-Henning Klusmann
Journal: Blood
Blood (2022) 139 (5): 651–665.
https://doi.org/10.1182/blood.2021012231
Published: 2022
Includes: Supplemental data